Adaptive designs in clinical trials: why use them, and how to run and report them

Abstract

Adaptive designs can make clinical trials more flexible by utilising results accumulating in the trial to modify the trial’s course in accordance with pre-specified rules. Trials with an adaptive design are often more efficient, informative and ethical than trials with a traditional fixed design since they often make better use of resources such as time and money, and might require fewer participants. Adaptive designs can be applied across all phases of clinical research, from early-phase dose escalation to confirmatory trials. The pace of the uptake of adaptive designs in clinical research, however, has remained well behind that of the statistical literature introducing new methods and highlighting their potential advantages. We speculate that one factor contributing to this is that the full range of adaptations available to trial designs, as well as their goals, advantages and limitations, remains unfamiliar to many parts of the clinical community. Additionally, the term adaptive design has been misleadingly used as an all-encompassing label to refer to certain methods that could be deemed controversial or that have been inadequately implemented.We believe that even if the planning and analysis of a trial is undertaken by an expert statistician, it is essential that the investigators understand the implications of using an adaptive design, for example, what the practical challenges are, what can (and cannot) be inferred from the results of such a trial, and how to report and communicate the results. This tutorial paper provides guidance on key aspects of adaptive designs that are relevant to clinical triallists. We explain the basic rationale behind adaptive designs, clarify ambiguous terminology and summarise the utility and pitfalls of adaptive designs. We discuss practical aspects around funding, ethical approval, treatment supply and communication with stakeholders and trial participants. Our focus, however, is on the interpretation and reporting of results from adaptive design trials, which we consider vital for anyone involved in medical research. We emphasise the general principles of transparency and reproducibility and suggest how best to put them into practice.

Designing clinical trials for future space missions as a pathway to changing how clinical trials are conducted on Earth

“…In these situations, one could implement stratified randomization to separate them by allocating them to groups. Moreover, the investigator could use weighted/unequal randomization which is still randomized but results in fewer participants allocated to the experimental group (or nonexperimental group whichever is deemed to have adverse consequences) (adaptive design) 11,12 . There are alternative methods for designing the clinical trial which can be used, such as patient‐preferred clinical trials, or different approaches to randomizing people to the groups, such as adaptive design clinical trials.…”

Exercise or manual physiotherapy compared with a single session of physiotherapy for osteoporotic vertebral fracture: three-arm PROVE RCT

“…In accordance with best practice guidance on adaptive trial design, we had conducted extensive simulations and agreed a clear interim analysis plan approved by the DMEC. 162, 163 The interim analysis was based on a comparison of the change in QUALEFFO-41 score at 4 months and indicated that the mean 4-month improvement in QUALEFFO-41 score was greater for both exercise therapy and manual therapy than SSPT (mean differences of -2.20 and -0.74 points for exercise therapy and manual therapy, respectively), although the differences were not statistically significant. On the basis of these mean values, it was decided to continue with both intervention arms and the SSPT arm, following the planned decision rule.…”

The Association Between Engagement and Weight Loss Through Personal Coaching and Cell Phone Interventions in Young Adults: Randomized Controlled Trial (Preprint)

“…The fact that engagement dropped substantially early within the constraint of a randomized controlled trial suggests that a more effective intervention, that automatically adapts to behavior and self-measured engagement such as using just in time adaptive design, may be needed. [34,35] …”